Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
NCT00585182
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Venous Thrombosis
Anticoagulants
Interventions
DRUG:
Enoxaparin 0.5 mg/kg once daily
Sponsor
University of Utah
Collaborators
[object Object]